Sunscreens - their special and unique non-GMP requirements - Dusanka Sabic Regulatory Reform Director, Accord Australasia November 2017

Page created by Jimmy Logan
 
CONTINUE READING
Sunscreens - their special and unique non-GMP requirements - Dusanka Sabic Regulatory Reform Director, Accord Australasia November 2017
Sunscreens – their special and unique
      non-GMP requirements

                                                  Dusanka Sabic
                  Regulatory Reform Director, Accord Australasia
                                                November 2017
Sunscreens - their special and unique non-GMP requirements - Dusanka Sabic Regulatory Reform Director, Accord Australasia November 2017
Sunscreens - their special and unique non-GMP requirements - Dusanka Sabic Regulatory Reform Director, Accord Australasia November 2017
What I will be covering today
Sunscreen regulation as cosmetics – impact of proposed changes
to industrial chemicals regulation
Changes to therapeutic goods regulation which impact on
sunscreens
Proposed sunscreen reform and implications for GMP
Other reforms which will impact on sunscreens
Sunscreens - their special and unique non-GMP requirements - Dusanka Sabic Regulatory Reform Director, Accord Australasia November 2017
Sunscreen regulation
Sunscreens are regulated as either cosmetics or therapeutic products
Cosmetic sunscreens are colour cosmetics, lip products, sunbathing
products (with any SPF) or moisturisers with SPF 15 or less
Therapeutic sunscreens are products used primarily for protection from
UV radiation, SPF 4 or more and moisturisers containing sunscreen with
SPF greater than 15 - includes insect repellants
Australian sunscreen standard defines secondary and primary
Sunscreens as cosmetics

New industrial chemicals framework – 1 July 2018?
Cosmetic standard will no longer apply
The TGA will articulate interface on cosmetic and therapeutic
requirements
Introduction of animal test ban for cosmetic ingredients
Overview of categorisation
Exposure band criteria - Key concepts
Ban on cosmetic animal testing – Overview
An election commitment to implement a ban commencing 1
July 2018
Extensive consultation including consumer survey
Part of industrial chemicals legislation reform package
Ban to follow international practice
Animal test ban proposal
As currently drafted, the legislation aligns with the EU ban
Chemicals with industrial uses other than in cosmetics can use
animal test data
Only cosmetic and personal care ingredients affected by the ban
Therapeutic goods are exempt
Development of Industry Code for consumer education and
cosmetic claims
Accord position on animal test ban
Committed to animal welfare and safety for consumers, workers
and the environment
Support a workable, practical, evidence-based approach
Supported the current bill as is aligned with major trading partners
and included realistic transition timeframe
We would have preferred to see cosmetic ingredients removed
from the scope of industrial chemicals legislation
Where are we now?
In June 2017, The Industrial Chemicals Bill 2017 was introduced
and read for the first time in parliament
The bill has passed the House of Representatives and sits in the
Senate
The delegated legislation is still under development
Commencement date of 1 July 2018 looks unlikely
Political environment is out of our control
Permissible Ingredients Determination
On 1 January 2016, a new legislative instrument under section 26BB of
the Therapeutic Goods Act 1989 commenced
This instrument brings together all of the ingredients that are available
for use in listed medicines and their associated requirements
Common issues raised by Accord members include:
   • Previously not all proprietary ingredients were required to be evaluated,
     flavors (5%), fragrances (1%) and inks (0.1%)
   • The TGA advised that implementation of 26BB would not change existing
     requirements nor result in any changes to industry business processes
   • Lack of transparency and timeliness of 26BB decisions and timing when an
     assessment would appear on the 26BB list and available for use
Labelling of Sunscreens as therapeutic goods
In August 2016 the new labelling order - TGO 92 Standard for labels of
non prescription medicines was introduced
A 4 year transition period for the implementation of TGO 92 to
eventually replace TGO 69
TGO 69 will remain in existence until the end of the 4 years
Full compliance with new requirements will be 1 September 2020
TGO 92 – sunscreen exemptions
Minor changes to current labelling requirements for sunscreens
Sunscreens may list the actives on side panel
Main label requirements do not apply to information on side or rear
panel – i.e. each active ingredient does not need to appear on a
separate line
Certain exemptions small containers – i.e. multiple active ingredients
presented on continuous line
Impact of Expert Review
Impact of reforms for complementary medicines have had an
unintended consequence for sunscreens
Any change to listed medicines impact on sunscreens, e.g.
permitted ingredients and permitted indications
Changes to advertising
Introduction of pharmacovigilance inspection programme
Permitted indications
September 2016 Government announcement that TGA will introduce a
list of permitted indications for all listed medicines
The purpose is to:
Ensure that listed medicines can only make low level indications
Provide transparency for sponsors on what indications are suitable for
listed medicines
Avoid consumers being misled by inappropriate indications
Permitted indications (cont’)
Permitted indications reforms to commence January 2018 with 3 year
transition period
Indications which are not compliant with AS/NZS 2604:2012 will not be
included in permitted indications list after 2021
Sunscreens compliant with AS/NZS 2604:1998 will not be able to make
claims such as SPF30+
Products not compliant with with new indications will be cancelled
Reforms to “low risk” therapeutic goods
Part of a wider review of medicines and medical devices
Recommended further review for “low risk” products of which
sunscreens is one product category
Also looked at range of other product categories such as:
 • Household disinfectants    • Antiseptic mouthwashes
 • Tampons                    • Antiperspirants
 • Desensitising toothpaste   • Acne products
Therapeutic sunscreen reform options
•   Status quo
•   Streamline regulatory pathways
•   Prevent secondary sunscreens from making SPF claims
•   Create GMP for primary sunscreens
•   New ingredient approval process
•   Alternative ingredient approval process
•   Exclude all sunscreens from regulatory framework
Accord position on sunscreen reform
Support all sunscreens regulated as cosmetics – but being pragmatic
this will not happen in Australia
Support all secondary sunscreens regulated as cosmetics
Support alternative GMP to PICS
Support streamlining of ingredient approvals
Support a regulatory instrument for all of the controls for primary
sunscreens regulated as therapeutic goods
Other initiatives which impact on sunscreens

 Revision of Australian sunscreen standard

 Unit measure – flexibility in quantity statement display

 Biosecurity – new requirements for imported products
Revision of sunscreen standard
ISO requires 5 year review of standards:

• ISO 2443 Determination of sunscreen UVA protection in vitro
• ISO 2444 Cosmetics-Sun protection test methods – In vivo
  determination of the sun protection factor (SPF)

This will also lead to review of AS/NZS 2604:2012
Unit measure – slow process to reform
2014 reform proposal to introduce flexibility of unit measurement mark or quantity
statement placement
Current requirement for quantity statement to be on front of pack
2015 industry consultation including consumer survey
2017 Options Paper to move towards flexible principles-based approach with 3
options for reform
Current favoured option is for principles-based approach requiring quantity
statement to be legible and prominent
Biosecurity – Cosmetic Case
BICON is the Australian Government's Biosecurity Import Conditions
database The BICON system replaced the Import Conditions (ICON)
database
Introduction of new arrangements has led to significant increase in
regulatory red tape for “low risk” finished cosmetic products
New arrangements commenced 16 June 2016
Biosecurity – Cosmetic Case
BICON now requires a manufacturer’s declaration or equivalent
(supplier’s declaration, invoice or product label) for all
consignments of cosmetics entering Australia.
Even for cosmetics that contain only synthetic chemicals.
Further documentation may be required for products containing
animal, microbial or plant derived ingredients.
More information at:
https://bicon.agriculture.gov.au/BiconWeb4.0/ImportConditions/Questions/EvaluateCase?elementID
=0000067907&elementVersionID=177
Thank you

   Dusanka Sabic
dsabic@accord.asn.au
   +61 422569222
You can also read